Month: August 2019

The Wilmington pharma secures a contract

The Wilmington pharma secures a contract

An eastern North Carolina CRO has handled an agreement with a worldwide biopharmaceutical organization with a rapidly extending exploration portfolio – adding to the company’s notoriety in oncology and immunology improvement. Wilmington-based Pharmaceutical Product Development – PPD – has reported an organization with Massachusetts-based Harbor Bio Med for the advancement […]

Growth Momentum in the Taiwan-based Semiconductor Foundries

Growth Momentum in the Taiwan-based Semiconductor Foundries

The recovery shown by semiconductor foundries which are Taiwan-based on an adequate increase in mid-2019 with global market demand is concluded by the observations of the Digitimes Research. The total revenues of 9.13 billion US dollars were gathered by three major companies TSMC (Taiwan Semiconductor Manufacturing Company), UMC (United Microelectronics […]

Taiwan Semiconductor Manufacturing Co. ranked number three in the first half of 2019

Taiwan Semiconductor Manufacturing Co. ranked number three in the first half of 2019

According to the latest market survey, Taiwan Semiconductor Manufacturing Co. (TSMC) was the third biggest chip provider in the world in the first half of 2019, while Taiwan-based MediaTek Inc. came in the list of top 15 IC chip providers for the first time. In a research study, market data […]

Organ-on-chip tech advanced by the researchers for boosting development of drug

Organ-on-chip tech advanced by the researchers for boosting development of drug

To evaluate heart cell electrophysiology in three dimensions, the researchers from Carnegie Mellon University (CMU) and Singapore’s Nanyang Technological University have created an organ-on-an-electronic chip platform that utilizes bioelectric detectors. These 3D, self-rolling biosensor arrays coil up over the spheroid tissues of heart cells to create an “organ-on-e-chip,” allowing researchers […]

Propanc Biopharma from Australia gets a United States Patent

Propanc Biopharma from Australia gets a United States Patent

Propanc Biopharma Inc., based in Melbourne, is a biopharmaceutical company that is developing new cancer treatments for the patients that are suffering from recurring or metastatic cancer. The company has announced the receiving of a granted United States patent from the United States Patent and Trademark Office (USPTO) that covers […]